Literature DB >> 20716553

Evaluation of the in vivo efficacy of intramuscularly administered ceftaroline fosamil, a novel cephalosporin, against a methicillin-resistant Staphylococcus aureus strain in a rabbit endocarditis model.

Cédric Jacqueline, Jocelyne Caillon, Eric Batard, Virginie Le Mabecque, Gilles Amador, Yigong Ge, Donald Biek, Gilles Potel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20716553     DOI： 10.1093/jac/dkq328

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

1.  Efficacy of Ceftaroline against Methicillin-Susceptible Staphylococcus aureus Exhibiting the Cefazolin High-Inoculum Effect in a Rat Model of Endocarditis.

Authors:  Kavindra V Singh; Truc T Tran; Esteban C Nannini; Vincent H Tam; Cesar A Arias; Barbara E Murray
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

2.  Ceftaroline fosamil: A novel anti-Methicillin-resistant Staphylococcus aureus cephalosporin.

Authors:  C Girish; S Balakrishnan
Journal:  J Pharmacol Pharmacother       Date:  2011-07

3.  Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia.

Authors:  Diego J Maselli; Juan F Fernandez; Christine Y Whong; Kelly Echevarria; Anoop M Nambiar; Antonio Anzueto; Marcos I Restrepo
Journal:  Infect Drug Resist       Date:  2012-02-01       Impact factor: 4.003

4.  Critical appraisal of ceftaroline in the management of community-acquired bacterial pneumonia and skin infections.

Authors:  Julian J Goodman; Stanley I Martin
Journal:  Ther Clin Risk Manag       Date:  2012-03-26       Impact factor: 2.423

5.  Ceftaroline fosamil: a brief clinical review.

Authors:  Debbie-Ann T Shirley; Emily L Heil; J Kristie Johnson
Journal:  Infect Dis Ther       Date:  2013-08-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.